Atria Wealth Solutions’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.07M Sell
10,036
-12,074
-55% -$1.22M 0.02% 611
2025
Q1
$2.23M Buy
22,110
+4,145
+23% +$417K 0.03% 595
2024
Q4
$1.6M Buy
17,965
+6,487
+57% +$571K 0.02% 724
2024
Q3
$962K Sell
11,478
-577
-5% -$45.5K 0.01% 930
2024
Q2
$928K Sell
12,055
-605
-5% -$44.3K 0.01% 927
2024
Q1
$867K Buy
12,660
+1,176
+10% +$75.6K 0.01% 974
2023
Q4
$664K Sell
11,484
-274
-2% -$14.6K 0.01% 1066
2023
Q3
$621K Buy
11,758
+6,316
+116% +$331K 0.01% 1032
2023
Q2
$294K Sell
5,442
-1,148
-17% -$60K ﹤0.01% 1457
2023
Q1
$330K Buy
6,590
+1,376
+26% +$64.8K ﹤0.01% 1359
2022
Q4
$241K Buy
5,214
+21
+0.4% +$909 ﹤0.01% 1491
2022
Q3
$201K Buy
+5,193
New +$208K ﹤0.01% 1556

Other funds holding BSX